Journal article icon

Journal article

Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology

Abstract:
This thesis explores virus-induced neuropathology using human stem cell-derived organotypic models that mimic the molecular and cellular complexity of the central nervous system (CNS). Chapter 1 introduces the challenges in studying viral neurological disease, emphasizing the limitations of traditional models and the potential of neural organoids as human-relevant systems. Chapter 2 highlights the importance of unified terminology and context-dependent host–virus interactions in understanding neuropathology.Part I focuses on modeling neuropathology caused by human Parechoviruses (HPeV) and Human Immunodeficiency Virus (HIV). Neural organoids were used to show that the neurovirulent HPeV-3, but not HPeV-1, induces strong immune and metabolic disturbances rather than differences in viral replication or tropism. Reanalysis revealed disrupted immunometabolism and glutamate excitotoxicity, implicating host metabolic imbalance in disease severity. Using microglia-containing organoids, HIV infection studies showed that microglia facilitate viral persistence, elevate HIV gene expression, and promote inflammatory amino acid metabolism, highlighting their role as reservoirs contributing to HIV-associated neurocognitive disorders.Part II applies organoid platforms for antiviral testing. Halofuginone Hydrobromide showed broad-spectrum antiviral potential in organoid systems but limited efficacy at clinically relevant concentrations, demonstrating the translational value of organoids for assessing both efficacy and toxicity.Together, these studies establish human iPSC-derived neural organoids as powerful models for studying viral infection, immune–metabolic crosstalk, and therapeutic interventions. Their multicellular architecture and human relevance position them as essential tools for mechanistic discovery, antiviral screening, and the advancement of precision medicine in neurovirology
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41593-024-01600-y
Publication website:
https://pure.uva.nl/ws/files/272362641/Chapter_1.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0002-7046-3348
More by this author
Role:
Author
ORCID:
0000-0001-5564-8179
More by this author
Role:
Author
ORCID:
0000-0002-8645-1317
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-5820-6333
More by this author
Role:
Author
ORCID:
0009-0003-5193-6722


More from this funder
Funder identifier:
10.13039/501100007660
Grant:
FFB210307
More from this funder
Funder identifier:
10.13039/100000957
Grant:
AARF-20-684397
More from this funder
Funder identifier:
10.13039/501100003130
Grant:
G0C9219N
More from this funder
Funder identifier:
10.13039/100010661
Grant:
CELLPHASE_AD


Publisher:
Nature Research
Journal:
Nature Neuroscience More from this journal
Volume:
27
Issue:
5
Pages:
886-900
Publication date:
2024-03-27
DOI:
EISSN:
1546-1726
ISSN:
1097-6256


Language:
English
Keywords:
Pubs id:
1989809
Local pid:
pubs:1989809
Source identifiers:
W4393225316
Deposit date:
2026-06-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP